Los Angeles Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,376
| Closed | -$660K | – | 1227 |
|
|
2024
Q3 | $660K | Buy |
+14,376
| New | +$660K | ﹤0.01% | 784 |
|
|
2024
Q2 | – | Sell |
-56,997
| Closed | -$1.45M | – | 1263 |
|
|
2024
Q1 | $1.45M | Sell |
56,997
-3,290
| -5% | -$84K | 0.01% | 576 |
|
|
2023
Q4 | $546K | Buy |
60,287
+1,030
| +2% | +$9.32K | ﹤0.01% | 841 |
|
|
2023
Q3 | $378K | Buy |
+59,257
| New | +$378K | ﹤0.01% | 903 |
|
|
2022
Q4 | – | Sell |
-12,025
| Closed | -$196K | – | 1268 |
|
|
2022
Q3 | $196K | Sell |
12,025
-5,670
| -32% | -$92.4K | ﹤0.01% | 1175 |
|
|
2022
Q2 | $257K | Sell |
17,695
-36,679
| -67% | -$533K | ﹤0.01% | 1194 |
|
|
2022
Q1 | $1M | Hold |
54,374
| – | – | ﹤0.01% | 760 |
|
|
2021
Q4 | $1.29M | Hold |
54,374
| – | – | ﹤0.01% | 635 |
|
|
2021
Q3 | $1.34M | Sell |
54,374
-6,000
| -10% | -$148K | 0.01% | 652 |
|
|
2021
Q2 | $1.49M | Sell |
60,374
-5,990
| -9% | -$148K | 0.01% | 679 |
|
|
2021
Q1 | $1.45M | Buy |
66,364
+1,826
| +3% | +$39.8K | 0.01% | 741 |
|
|
2020
Q4 | $1.65M | Buy |
+64,538
| New | +$1.65M | 0.01% | 731 |
|